US7189834B2
(en)
*
|
1993-05-11 |
2007-03-13 |
Marshall William E |
Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
|
US20030109469A1
(en)
*
|
1993-08-26 |
2003-06-12 |
Carson Dennis A. |
Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
|
US6727230B1
(en)
*
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US6429199B1
(en)
*
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US7935675B1
(en)
*
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US7422902B1
(en)
*
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
US5981501A
(en)
*
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
US6406705B1
(en)
*
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
JP4656675B2
(ja)
*
|
1997-05-14 |
2011-03-23 |
ユニバーシティー オブ ブリティッシュ コロンビア |
脂質小胞への荷電した治療剤の高率封入
|
CA2328406A1
(en)
*
|
1998-05-14 |
1999-11-18 |
Hermann Wagner |
Methods for regulating hematopoiesis using cpg-oligonucleotides
|
NZ508927A
(en)
|
1998-05-22 |
2003-12-19 |
Ottawa Health Research Inst |
Methods and products for inducing mucosal immunity
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
JP5084984B2
(ja)
|
1999-02-17 |
2012-11-28 |
シーエスエル、リミテッド |
免疫原複合体およびそれに関する方法
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
US20050002958A1
(en)
*
|
1999-06-29 |
2005-01-06 |
Smithkline Beecham Biologicals Sa |
Vaccines
|
ATE419869T1
(de)
|
1999-08-19 |
2009-01-15 |
Dynavax Tech Corp |
Methode zur modulierung eines immunantwortes mit immunstimulierenden sequencen und zusammensetzungen dafür
|
RU2245149C2
(ru)
*
|
1999-09-25 |
2005-01-27 |
Юниверсити Оф Айова Рисерч Фаундейшн |
Иммуностимулирующие нуклеиновые кислоты
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
MXPA02005842A
(es)
*
|
1999-12-13 |
2003-10-14 |
Bioniche Life Sciences Inc |
Oligonucleotidos sinteticos terapeuticamente utiles.
|
DE60131430T2
(de)
*
|
2000-01-14 |
2008-10-16 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
|
EP1253947A4
(en)
|
2000-01-31 |
2005-01-05 |
Univ California |
IMMUNOMODULATED POLYNUCLEOTIDES FOR THE TREATMENT OF INFECTIONS BY INTRA-CELLULAR DISEASES
|
US7585847B2
(en)
*
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
US6613751B2
(en)
|
2000-02-23 |
2003-09-02 |
The Regents Of The University Of California |
Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
NZ521898A
(en)
|
2000-03-31 |
2004-11-26 |
Purdue Research Foundation |
Use of a ligand-immunogen conjugate such as folate-FITC for enhancing an endogenous immune response
|
WO2001093905A1
(en)
|
2000-06-08 |
2001-12-13 |
Intercell Biomedizinische Forschungs- Und Entwicklungs Ag |
Immunostimulatory oligodeoxynucleotides
|
JP2003535907A
(ja)
*
|
2000-06-22 |
2003-12-02 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
抗体誘導性細胞溶解を促進し、そして癌を処置するための方法
|
US7767197B2
(en)
|
2000-06-22 |
2010-08-03 |
Endo Pharmaceuticals Colorado LLC |
Delivery vehicle composition and methods for delivering antigens and other drugs
|
KR100917101B1
(ko)
*
|
2000-08-04 |
2009-09-15 |
도요 보세키 가부시키가이샤 |
플렉시블 금속적층체 및 그 제조방법
|
CA2419894A1
(en)
|
2000-09-15 |
2002-03-21 |
Coley Pharmaceutical Gmbh |
Process for high throughput screening of cpg-based immuno-agonist/antagonist
|
EP1350262B8
(en)
*
|
2000-12-08 |
2008-08-13 |
Coley Pharmaceuticals GmbH |
Cpg-like nucleic acids and methods of use thereof
|
WO2002052002A2
(en)
|
2000-12-27 |
2002-07-04 |
Dynavax Technologies Corporation |
Immunomodulatory polynucleotides and methods of using the same
|
US7785610B2
(en)
*
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
US20040132677A1
(en)
*
|
2001-06-21 |
2004-07-08 |
Fearon Karen L. |
Chimeric immunomodulatory compounds and methods of using the same-IV
|
DK2423335T3
(da)
|
2001-06-21 |
2014-08-18 |
Dynavax Tech Corp |
Kimæriske immunmodulatoriske forbindelser og fremgangsmåder til anvendelse deraf
|
JP4370161B2
(ja)
*
|
2001-06-29 |
2009-11-25 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
Hcve1e2ワクチン組成物
|
US7666674B2
(en)
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
EP1420829A4
(en)
|
2001-08-07 |
2006-05-17 |
Dynavax Tech Corp |
IMMUNOMODULATING COMPOSITIONS, FORMULATIONS AND METHOD FOR THEIR USE
|
US7354909B2
(en)
*
|
2001-08-14 |
2008-04-08 |
The United States Of America As Represented By Secretary Of The Department Of Health And Human Services |
Method for rapid generation of mature dendritic cells
|
IL160157A0
(en)
*
|
2001-08-17 |
2004-07-25 |
Coley Pharm Group Inc |
Combination motif immune stimulation oligonucleotides with improved activity
|
AU2008200021A1
(en)
*
|
2001-08-17 |
2008-01-31 |
Coley Pharmaceutical Gmbh |
Combination motif immune stimulatory oligonucleotides with improved activity
|
US7709451B2
(en)
*
|
2001-09-07 |
2010-05-04 |
Trustees Of Boston University |
Method and composition for treating immune complex associated disorders
|
EP1450856B1
(en)
|
2001-09-14 |
2009-11-11 |
Cytos Biotechnology AG |
Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
|
WO2003028634A2
(en)
*
|
2001-09-28 |
2003-04-10 |
Purdue Research Foundation |
Method of treatment using ligand-immunogen conjugates
|
WO2003030656A2
(en)
|
2001-10-06 |
2003-04-17 |
Merial Limited |
Methods and compositions for promoting growth and innate immunity in young animals
|
JP2005519990A
(ja)
*
|
2001-10-12 |
2005-07-07 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
イミダゾキノリン化合物を用いて免疫応答を増強するための方法および産物
|
US7276489B2
(en)
*
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
AU2002340662B2
(en)
*
|
2001-11-07 |
2008-07-03 |
Tekmira Pharmaceuticals Corporation |
Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
|
US8466116B2
(en)
|
2001-12-20 |
2013-06-18 |
The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce epithelial cell growth
|
AU2002366710A1
(en)
*
|
2001-12-20 |
2003-07-09 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
AU2002357359B2
(en)
|
2001-12-21 |
2009-01-08 |
Csl Limited |
Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
|
US8088388B2
(en)
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
NZ573064A
(en)
|
2002-04-04 |
2011-02-25 |
Coley Pharm Gmbh |
Immunostimulatory G,U-containing oligoribonucleotides
|
EP1497424A1
(en)
*
|
2002-04-22 |
2005-01-19 |
Bioniche Life Sciences Inc. |
Oligonucleotide compositions and their use for the modulation of immune responses
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
US20040009944A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Methylated immunostimulatory oligonucleotides and methods of using the same
|
US20040009943A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Pathogen vaccines and methods for using the same
|
KR100456681B1
(ko)
*
|
2002-05-22 |
2004-11-10 |
주식회사 대웅 |
박테리아의 염색체 dna 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물
|
CA2388049A1
(en)
*
|
2002-05-30 |
2003-11-30 |
Immunotech S.A. |
Immunostimulatory oligonucleotides and uses thereof
|
JP4598519B2
(ja)
*
|
2002-06-20 |
2010-12-15 |
サイトス バイオテクノロジー アーゲー |
アジュバントとして使用するためのパッケージ化されたウィルス様粒子:調製法及び使用法
|
US20040101534A1
(en)
*
|
2002-06-25 |
2004-05-27 |
Diamond Don J. |
Adjuvant-free peptide vaccine
|
US7605138B2
(en)
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7807803B2
(en)
|
2002-07-03 |
2010-10-05 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
CA2494508A1
(en)
*
|
2002-07-03 |
2004-01-15 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US20040053880A1
(en)
|
2002-07-03 |
2004-03-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7576066B2
(en)
|
2002-07-03 |
2009-08-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7569553B2
(en)
|
2002-07-03 |
2009-08-04 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
SG166673A1
(en)
*
|
2002-08-19 |
2010-12-29 |
Coley Pharm Group Inc |
Immunostimulatory nucleic acids
|
AR040996A1
(es)
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
KR101360955B1
(ko)
*
|
2002-09-13 |
2014-02-10 |
레플리코르 인코포레이티드 |
비서열 상보적 항바이러스 올리고뉴클레오티드
|
US8263091B2
(en)
|
2002-09-18 |
2012-09-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
|
BR0315810A
(pt)
|
2002-10-29 |
2005-09-13 |
Coley Pharmaceutical Group Ltd |
Uso de oligonucleotìdeos cpg no tratamento de infecção por vìrus da hepatite c
|
CA2504493C
(en)
|
2002-11-01 |
2015-12-29 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides
|
EP1578954A4
(en)
|
2002-12-11 |
2010-08-11 |
Coley Pharm Group Inc |
5'-CPG NUCLEIC ACIDS AND USE METHOD
|
TW201139672A
(en)
|
2002-12-13 |
2011-11-16 |
Novartis Ag |
Immunization of fish with plant-expressed recombinant proteins
|
SG2011035342A
(en)
|
2002-12-23 |
2016-12-29 |
Dynavax Tech Corp |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
JP2006516099A
(ja)
|
2002-12-23 |
2006-06-22 |
ダイナバックス テクノロジーズ コーポレイション |
分枝状の免疫調節化合物及び該化合物の使用方法
|
JP4976848B2
(ja)
|
2003-02-20 |
2012-07-18 |
ユニバーシティー オブ コネティカット ヘルス センター |
アルファ(2)マクログロブリン−抗原分子複合体を用いる癌および感染性疾患の治療のための方法および組成物
|
US7537767B2
(en)
|
2003-03-26 |
2009-05-26 |
Cytis Biotechnology Ag |
Melan-A- carrier conjugates
|
WO2004084940A1
(en)
*
|
2003-03-26 |
2004-10-07 |
Cytos Biotechnology Ag |
Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
|
EP1608403A2
(en)
*
|
2003-04-02 |
2005-12-28 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations for topical application
|
PL1610850T3
(pl)
*
|
2003-04-09 |
2012-11-30 |
Novartis Ag |
Urządzenie rozpylające z osłoną wlotu powietrza
|
US7790189B2
(en)
*
|
2003-05-15 |
2010-09-07 |
Mitsui Sugar Co., Ltd. |
Immunostimulating agents
|
EA200600069A1
(ru)
*
|
2003-06-20 |
2006-08-25 |
Коли Фармасьютикал Гмбх |
Низкомолекулярные антагонисты toll-подобных рецепторов (tlr)
|
KR20060031607A
(ko)
|
2003-07-10 |
2006-04-12 |
사이토스 바이오테크놀로지 아게 |
패킹된 바이러스-양 입자
|
US20070219149A1
(en)
*
|
2003-08-11 |
2007-09-20 |
The Research Foundation For Microbial Diseases Of Osaka University |
Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity
|
DK1656026T3
(da)
|
2003-08-22 |
2014-07-14 |
Dupont Nutrition Biosci Aps |
Sammensætning, der omfatter et bakteriocin og et ekstrakt fra en plante fra læbeblomstfamilien
|
GB2388581A
(en)
|
2003-08-22 |
2003-11-19 |
Danisco |
Coated aqueous beads
|
EP2289547B1
(en)
|
2003-09-12 |
2015-12-16 |
Agenus Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
AU2004275876B2
(en)
*
|
2003-09-25 |
2011-03-31 |
Coley Pharmaceutical Gmbh |
Nucleic acid-lipophilic conjugates
|
EP1675614A2
(en)
*
|
2003-10-11 |
2006-07-05 |
Inex Pharmaceuticals Corp. |
Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
|
SG123799A1
(en)
|
2003-10-30 |
2006-07-26 |
Coley Pharm Gmbh |
C-class oligonucleotide analogs with enchanced immunostimulatory potency
|
US20050239733A1
(en)
*
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
US20050100983A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Coley Pharmaceutical Gmbh |
Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling
|
JP2007530449A
(ja)
*
|
2003-12-08 |
2007-11-01 |
イデラ ファーマシューティカルズ インコーポレイテッド |
小オリゴヌクレオチドに基づく化合物による免疫刺激特性の調節
|
DE10361502A1
(de)
*
|
2003-12-23 |
2005-07-28 |
Phenion Gmbh & Co. Kg |
Kosmetische oder pharmazeutische Zubereitungen enthaltend Superstruktur-bildende Nukleinsäure-Sequenzen
|
KR100558851B1
(ko)
*
|
2004-01-08 |
2006-03-10 |
학교법인연세대학교 |
면역조절능력이 증가된 CpG 올리고데옥시뉴클레오티드변형체
|
US7973016B2
(en)
*
|
2004-01-23 |
2011-07-05 |
Joslin Diebetes Center |
Methods of treating, reducing, or preventing autoimmune conditions
|
US20050256073A1
(en)
*
|
2004-02-19 |
2005-11-17 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory viral RNA oligonucleotides
|
EP1730281A2
(en)
*
|
2004-04-02 |
2006-12-13 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing il-10 responses
|
AU2005326144A1
(en)
*
|
2004-06-08 |
2006-08-03 |
Coley Pharmaceutical Gmbh |
Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist
|
US7674456B2
(en)
*
|
2004-06-14 |
2010-03-09 |
Charles Wiseman |
Breast cancer cell lines and uses thereof
|
KR100958505B1
(ko)
|
2004-07-18 |
2010-05-17 |
씨에스엘 리미티드 |
면역자극 복합체 및 향상된 인터페론-감마 반응을 유도하기위한 올리고뉴클레오티드 제제
|
JP4550115B2
(ja)
*
|
2004-08-03 |
2010-09-22 |
ジーンアート・アクチエンゲゼルシャフト |
CpG含量を変化させることにより遺伝子発現を調整する方法
|
KR101268877B1
(ko)
|
2004-09-01 |
2013-05-31 |
다이나박스 테크놀로지 코퍼레이션 |
선천성 면역반응 및 자가면역의 억제를 위한 방법 및조성물
|
MY159370A
(en)
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
EP1657307A1
(en)
*
|
2004-11-16 |
2006-05-17 |
Immunotech S.A. |
Oligonucleotides that induce the secretion of GM-CSF
|
JP2008531018A
(ja)
*
|
2005-02-24 |
2008-08-14 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
免疫刺激性オリゴヌクレオチド
|
JP5403457B2
(ja)
*
|
2005-02-28 |
2014-01-29 |
株式会社明治 |
Atオリゴヌクレオチドを有効成分とする免疫応答増強性薬剤及び食品組成物
|
CN101171033A
(zh)
*
|
2005-03-04 |
2008-04-30 |
戴纳瓦克斯技术公司 |
包含具免疫刺激序列iss之寡核苷酸的疫苗:其中iss与抗原缀合并通过缓冲条件和其他赋形剂稳定
|
PT1868642E
(pt)
|
2005-03-18 |
2013-07-10 |
Cytos Biotechnology Ag |
Proteínas de fusão de alergénios de gato e suas utilizações
|
CA2603976A1
(en)
*
|
2005-04-08 |
2006-10-19 |
Coley Pharmaceutical Group, Inc. |
Methods for treating infectious disease exacerbated asthma
|
EP1868628B1
(en)
|
2005-04-08 |
2014-06-11 |
Chimerix, Inc. |
Compounds, compositions and methods for the treatment of poxvirus infections
|
MX2007013156A
(es)
|
2005-04-28 |
2008-01-18 |
Novo Nordisk Healthcare Ag |
Envase cerrado que comprende un polipeptido del factor vii activado, procesos para la preparacion del mismo y kit y metodo para el uso del kit.
|
DE102005022290A1
(de)
*
|
2005-05-13 |
2006-11-16 |
Universitätsklinikum Schleswig-Holstein |
Hexanukleotid-Wirkstoffe
|
CN1865275B
(zh)
|
2005-05-17 |
2011-06-15 |
长春华普生物技术有限公司 |
对人b细胞肿瘤有治疗作用的人工合成的单链脱氧核苷酸
|
PL2269622T3
(pl)
|
2005-07-01 |
2014-05-30 |
Index Pharmaceuticals Ab |
Sposób do modulowania wrażliwości na steroidy
|
DK2179737T3
(da)
|
2005-07-01 |
2013-11-11 |
Index Pharmaceuticals Ab |
Modulering af respons på steroider
|
EP1904530A2
(en)
*
|
2005-07-07 |
2008-04-02 |
Coley Pharmaceutical Group, Inc. |
Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
|
WO2007031877A2
(en)
*
|
2005-09-16 |
2007-03-22 |
Coley Pharmaceutical Gmbh |
Modulation of immunostimulatory properties of short interfering ribonucleic acid (sirna) by nucleotide modification
|
EA013468B1
(ru)
*
|
2005-09-16 |
2010-04-30 |
Коли Фармасьютикал Гмбх |
Иммуностимулирующая одноцепочечная рибонуклеиновая кислота с фосфодиэфирным остовом
|
US8895522B2
(en)
|
2005-10-28 |
2014-11-25 |
Index Pharmaceuticals Ab |
Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease
|
WO2007056061A2
(en)
*
|
2005-11-02 |
2007-05-18 |
Duke University |
Concurrent chemotherapy and immunotherapy
|
CN102755645A
(zh)
|
2005-11-04 |
2012-10-31 |
诺华疫苗和诊断有限公司 |
佐剂配制的包含细胞因子诱导剂的流感疫苗
|
AU2006310163B2
(en)
|
2005-11-04 |
2011-09-15 |
Seqirus UK Limited |
Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
|
JP2009514838A
(ja)
|
2005-11-04 |
2009-04-09 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル |
細胞培養物において増殖されたインフルエンザウイルスから調製された非ビリオン抗原を含むアジュバントワクチン
|
ES2377884T3
(es)
|
2005-11-04 |
2012-04-02 |
Novartis Vaccines And Diagnostics S.R.L. |
Vacunas contra la gripe que incluyen combinaciones de adyuvantes particulados e inmunopotenciadores
|
CN102864152B
(zh)
*
|
2005-11-07 |
2015-11-18 |
艾德拉药物股份有限公司 |
包含经修饰的免疫刺激性二核苷酸的基于寡核苷酸的化合物之免疫刺激特性
|
CA2630738C
(en)
|
2005-11-25 |
2013-09-03 |
Coley Pharmaceutical Gmbh |
Immunostimulatory oligoribonucleotides
|
EP1973608A1
(en)
|
2005-12-14 |
2008-10-01 |
Cytos Biotechnology AG |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
DK2478916T3
(da)
|
2006-01-27 |
2020-06-15 |
Seqirus Uk Ltd |
Influenzavacciner indeholdende hæmagglutinin og matrixproteiner
|
RU2008135318A
(ru)
*
|
2006-02-01 |
2010-03-10 |
Дзе Джонс Хопкинс Юниверсити (Us) |
Конъюгат полипептид-нуклеиновая кислота для иммунопрофилактики или иммунотерапии неопластических или инфекционных заболеваний
|
WO2007092299A2
(en)
|
2006-02-03 |
2007-08-16 |
Purdue Research Foundation |
Targeted conjugates and radiation
|
PT2405002E
(pt)
*
|
2006-02-15 |
2015-01-05 |
Adiutide Pharmaceuticals Gmbh |
Composições e métodos para formulações de oligonucleotídeos
|
CN100418583C
(zh)
*
|
2006-02-21 |
2008-09-17 |
朱鸿飞 |
预防和治疗乳腺炎的药物组合物
|
CA2646349A1
(en)
|
2006-03-24 |
2007-10-04 |
Novartis Vaccines And Diagnostics Gmbh & Co Kg |
Storage of influenza vaccines without refrigeration
|
US9107863B2
(en)
|
2006-03-27 |
2015-08-18 |
The Buck Institute For Age Reasearch |
Reagents and methods for cancer treatment and prevention
|
WO2007126825A2
(en)
|
2006-03-31 |
2007-11-08 |
Novartis Ag |
Combined mucosal and parenteral immunization against hiv
|
ES2471978T3
(es)
|
2006-05-05 |
2014-06-27 |
Isis Pharmaceuticals, Inc. |
Compuestos y procedimientos para modular la expresión de ApoB
|
RU2464030C2
(ru)
*
|
2006-05-26 |
2012-10-20 |
Регадо Байосайенсиз, Инк. |
Введение противосвертывающей системы reg1
|
US20100015168A1
(en)
|
2006-06-09 |
2010-01-21 |
Novartis Ag |
Immunogenic compositions for streptococcus agalactiae
|
SG172696A1
(en)
|
2006-06-12 |
2011-07-28 |
Cytos Biotechnology Ag |
Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
|
CA2656266C
(en)
|
2006-06-20 |
2012-07-31 |
Transgene S.A. |
Recombinant viral vaccine
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
ES2694805T7
(es)
|
2006-09-11 |
2021-10-21 |
Seqirus Uk Ltd |
Fabricación de vacunas contra virus de la gripe sin usar huevos
|
NZ575437A
(en)
|
2006-09-27 |
2012-02-24 |
Coley Pharm Gmbh |
Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
|
US20090142362A1
(en)
*
|
2006-11-06 |
2009-06-04 |
Avant Immunotherapeutics, Inc. |
Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)
|
SG177141A1
(en)
|
2006-12-06 |
2012-01-30 |
Novartis Ag |
Vaccines including antigen from four strains of influenza virus
|
UA100370C2
(uk)
|
2006-12-11 |
2012-12-25 |
Мериал Лимитед |
Спосіб вакцинації птахів проти salmonella
|
AU2007333147B2
(en)
|
2006-12-12 |
2013-12-19 |
Kuros Us Llc |
Oligonucleotides containing high concentrations of guanine monomers
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
EP2185191B1
(en)
|
2007-06-27 |
2012-09-12 |
Novartis AG |
Low-additive influenza vaccines
|
CA2695385A1
(en)
*
|
2007-07-31 |
2009-02-05 |
Atul Bedi |
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
WO2009055076A2
(en)
*
|
2007-10-26 |
2009-04-30 |
Dynavax Technologies Corporation |
Methods and compositions for inhibition of immune responses and autoimmunity
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
GB0818453D0
(en)
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
EP2254582B1
(en)
|
2008-01-25 |
2016-01-20 |
Chimerix, Inc. |
Methods of treating viral infections
|
CN101998990B
(zh)
|
2008-03-18 |
2013-11-27 |
诺华股份有限公司 |
流感病毒疫苗抗原制备方法的改进
|
MX2010012069A
(es)
|
2008-05-08 |
2010-12-14 |
Merial Ltd |
Vacuna de la leishmaniasis con el uso del inmunogeno salival de la mosca de la arena.
|
TWI351288B
(en)
*
|
2008-07-04 |
2011-11-01 |
Univ Nat Pingtung Sci & Tech |
Cpg dna adjuvant in avian vaccines
|
BRPI0923225A2
(pt)
|
2008-12-02 |
2016-10-04 |
Chiralgen Ltd |
metodo para sintese de acidos nucleicos modificados no atomo de fosforo
|
US20110294870A1
(en)
*
|
2008-12-04 |
2011-12-01 |
Opko Curna, Llc |
Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
|
WO2010067262A1
(en)
|
2008-12-09 |
2010-06-17 |
Pfizer Inc. |
Immunostimulatory oligonucleotides
|
US8552165B2
(en)
*
|
2008-12-09 |
2013-10-08 |
Heather Davis |
Immunostimulatory oligonucleotides
|
KR101805199B1
(ko)
*
|
2009-02-12 |
2017-12-05 |
큐알엔에이, 인크. |
신경교세포 유래된 신경영양성 인자 (gdnf)에 대한 자연 안티센스 전사체의 저해에 의한 신경교세포 유래된 신경영양성 인자 (gdnf) 관련된 질환의 치료
|
DK2396038T3
(en)
*
|
2009-02-12 |
2016-02-01 |
Curna Inc |
TREATMENT OF BRAIN-DERIVATED NEUROTROPHIC FACTOR- (BDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENCE TRANSCRIPTION TO BDNF
|
RU2011140508A
(ru)
|
2009-03-06 |
2013-04-20 |
Новартис Аг |
Антигены хламидии
|
JP5759445B2
(ja)
|
2009-03-25 |
2015-08-05 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
病原体に対する哺乳類先天性免疫抵抗性の刺激のための組成物
|
WO2010115118A2
(en)
|
2009-04-03 |
2010-10-07 |
Antigenics, Inc. |
Methods for preparing and using multichaperone-antigen complexes
|
CN109248313B
(zh)
|
2009-04-14 |
2023-01-17 |
葛兰素史密丝克莱恩生物有限公司 |
用于免疫接种以抵御金黄色葡萄球菌的组合物
|
USH2284H1
(en)
|
2009-04-27 |
2013-09-03 |
Novartis Ag |
Vaccines for protecting against influenza
|
KR101885383B1
(ko)
|
2009-07-06 |
2018-08-03 |
웨이브 라이프 사이언시스 리미티드 |
신규한 핵산 프로드러그 및 그의 사용 방법
|
JP2012532600A
(ja)
|
2009-07-07 |
2012-12-20 |
ノバルティス アーゲー |
保存された大腸菌免疫原
|
ES2918381T3
(es)
|
2009-07-15 |
2022-07-15 |
Glaxosmithkline Biologicals Sa |
Composiciones de proteína F de VRS y métodos para producir las mismas
|
PT2464658E
(pt)
|
2009-07-16 |
2015-01-14 |
Novartis Ag |
Imunogénios de escherichia coli desintoxicados
|
US20120252869A1
(en)
*
|
2009-07-24 |
2012-10-04 |
Opko Curna, Llc |
Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
|
NO2480669T3
(no)
|
2009-09-25 |
2018-04-07 |
|
|
GB0918392D0
(en)
|
2009-10-20 |
2009-12-02 |
Novartis Ag |
Diagnostic and therapeutic methods
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
WO2011062997A2
(en)
|
2009-11-17 |
2011-05-26 |
Musc Foundation For Research Development |
Human monoclonal antibodies to human nucleolin
|
CN106399482B
(zh)
|
2009-11-23 |
2021-04-27 |
拜尔作物科学股份有限公司 |
耐除草剂大豆植物及鉴定其的方法
|
EP2504454B1
(en)
|
2009-11-23 |
2018-11-21 |
Bayer CropScience NV |
Elite event ee-gm3 and methods and kits for identifying such event in biological samples
|
EP2519265B1
(en)
|
2009-12-30 |
2018-11-14 |
GlaxoSmithKline Biologicals SA |
Polysaccharide immunogens conjugated to e. coli carrier proteins
|
US9006218B2
(en)
|
2010-02-12 |
2015-04-14 |
Chimerix Inc. |
Nucleoside phosphonate salts
|
EP2563367A4
(en)
|
2010-04-26 |
2013-12-04 |
Chimerix Inc |
METHODS OF TREATING RETROVIRAL INFECTIONS AND ASSOCIATED DOSAGE REGIMES
|
EA023397B1
(ru)
|
2010-05-26 |
2016-05-31 |
Селекта Байосайенсиз, Инк. |
Комбинированные вакцины с синтетическими наноносителями
|
GB201009861D0
(en)
|
2010-06-11 |
2010-07-21 |
Novartis Ag |
OMV vaccines
|
CA2802873C
(en)
|
2010-06-16 |
2018-09-18 |
Dynavax Technologies Corporation |
Methods of treatment using tlr7 and/or tlr9 inhibitors
|
RU2588654C2
(ru)
*
|
2010-06-23 |
2016-07-10 |
Курна, Инк. |
Лечение заболеваний, связанных с альфа-субъединицей потенциалзависимого натриевого канала (scna), путем ингибирования природного антисмыслового транскрипта гена scna
|
MX2013000164A
(es)
*
|
2010-07-06 |
2013-03-05 |
Novartis Ag |
Liposomas con lipidos que tienen valor de pka ventajoso para suministro de arn.
|
JP5868324B2
(ja)
|
2010-09-24 |
2016-02-24 |
株式会社Wave Life Sciences Japan |
不斉補助基
|
WO2012061717A1
(en)
|
2010-11-05 |
2012-05-10 |
Selecta Biosciences, Inc. |
Modified nicotinic compounds and related methods
|
PT2667892T
(pt)
|
2011-01-26 |
2019-06-07 |
Glaxosmithkline Biologicals Sa |
Regime de imunização contra o vsr
|
US10941399B2
(en)
*
|
2011-04-14 |
2021-03-09 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for gene-specific demethylation by DNA methyltransferase (DNMT)-RNA interaction
|
PT2707385T
(pt)
|
2011-05-13 |
2017-12-19 |
Glaxosmithkline Biologicals Sa |
Antigénios de f de rsv pré-fusão
|
CN108014334B
(zh)
|
2011-05-20 |
2021-11-30 |
H.伦德贝克公司 |
抗cgrp抗体和抗体片段用于在有需要的受试者中预防或抑制畏光或厌光的用途
|
EA033109B1
(ru)
|
2011-05-20 |
2019-08-30 |
Олдербайо Холдингз Ллк |
Способы ингибирования, профилактики или лечения диареи и/или поддержания соответствующих уровней электролитов и жидкости в толстой кишке субъекта, подвергающегося связанному с диареей состоянию, с помощью антитела против cgrp или фрагмента антитела против cgrp
|
EA201891284A1
(ru)
|
2011-05-20 |
2018-11-30 |
Олдербайо Холдингз Ллк |
Композиции антител против cgrp и их применение
|
WO2013006837A1
(en)
*
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Cationic oil-in-water emulsions
|
CN103764171B
(zh)
|
2011-07-08 |
2016-08-17 |
诺华股份有限公司 |
酪氨酸连接方法
|
US9693957B2
(en)
|
2011-07-08 |
2017-07-04 |
The University Of North Carolina At Chapel Hill |
Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
|
CN103796657B
(zh)
|
2011-07-19 |
2017-07-11 |
波涛生命科学有限公司 |
合成官能化核酸的方法
|
LT2734230T
(lt)
|
2011-07-20 |
2019-03-25 |
Merial Limited |
Rekombinantinė kačių leikemijos viruso vakcina, turinti optimizuotą kačių leukemijos viruso apvalkalo geną
|
AU2012290306B2
(en)
|
2011-07-29 |
2017-08-17 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers that generate humoral and cytotoxic T lymphocyte (CTL) immune responses
|
JP6170932B2
(ja)
|
2011-11-07 |
2017-07-26 |
ノバルティス アーゲー |
spr0096抗原およびspr2021抗原を含むキャリア分子
|
US20150045248A1
(en)
*
|
2012-02-28 |
2015-02-12 |
National University Corporation Tokyo University Of Agriculture And Technology |
Method for identifying disease associated with abundance of tdp-43 in cell
|
WO2013142371A1
(en)
|
2012-03-20 |
2013-09-26 |
Merial Limited |
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
|
JP2014012650A
(ja)
*
|
2012-07-05 |
2014-01-23 |
Nihon Univ |
上皮バリア機能の増強方法及び増強剤
|
EP4219516A3
(en)
|
2012-07-13 |
2024-01-10 |
Wave Life Sciences Ltd. |
Chiral control
|
SG11201500239VA
(en)
|
2012-07-13 |
2015-03-30 |
Wave Life Sciences Japan |
Asymmetric auxiliary group
|
EP2873674B1
(en)
*
|
2012-07-13 |
2020-05-06 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant
|
CA2883296A1
(en)
|
2012-08-30 |
2014-03-06 |
Merial, Inc. |
Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
|
EA201590427A1
(ru)
|
2012-10-02 |
2015-09-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Нелинейные сахаридные конъюгаты
|
AU2013351182C1
(en)
|
2012-11-30 |
2018-11-08 |
Glaxosmithkline Biologicals Sa |
Pseudomonas antigens and antigen combinations
|
CA2899241C
(en)
|
2013-02-20 |
2023-03-28 |
Innate Pharma |
A compound that specifically binds to kir3dl2 for use in the treatment of peripheral t cell lymphoma
|
US9427647B2
(en)
*
|
2013-04-26 |
2016-08-30 |
Russell I. Moy |
Climbing hold assembly having load dissipative effect
|
WO2014191936A1
(en)
|
2013-05-29 |
2014-12-04 |
Institut National De La Sante Et De La Recherche Medicale |
Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomas
|
WO2014201245A1
(en)
|
2013-06-12 |
2014-12-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors
|
AU2014292926B2
(en)
|
2013-07-25 |
2020-03-05 |
Exicure Operating Company |
Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
|
EP2870974A1
(en)
|
2013-11-08 |
2015-05-13 |
Novartis AG |
Salmonella conjugate vaccines
|
WO2015108047A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
|
US10322173B2
(en)
|
2014-01-15 |
2019-06-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
JPWO2015108048A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
KR102423317B1
(ko)
|
2014-01-16 |
2022-07-22 |
웨이브 라이프 사이언시스 리미티드 |
키랄 디자인
|
PL3164113T3
(pl)
|
2014-06-04 |
2019-09-30 |
Exicure, Inc. |
Wielowartościowe dostarczanie modulatorów immunologicznych w liposomowych kolistych kwasach nukleinowych do zastosowań profilaktycznych lub terapeutycznych
|
US10286065B2
(en)
|
2014-09-19 |
2019-05-14 |
Board Of Regents, The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
CA2968531A1
(en)
|
2014-11-21 |
2016-05-26 |
Northwestern University |
The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
|
EA201792501A1
(ru)
|
2015-05-13 |
2018-10-31 |
Эйдженус Инк. |
Вакцины для лечения и профилактики рака
|
KR20180035807A
(ko)
|
2015-06-26 |
2018-04-06 |
세퀴러스 유케이 리미티드 |
항원적으로 매치된 인플루엔자 백신
|
EP3468605A4
(en)
|
2016-06-08 |
2020-01-08 |
President and Fellows of Harvard College |
MODIFIED VIRAL VECTOR REDUCING THE INDUCTION OF INFLAMMATORY AND IMMUNE RESPONSES
|
EP3490598A1
(en)
*
|
2016-07-26 |
2019-06-05 |
Bayer Animal Health GmbH |
Increased fertility in bovine species
|
US11364304B2
(en)
|
2016-08-25 |
2022-06-21 |
Northwestern University |
Crosslinked micellar spherical nucleic acids
|
US11696954B2
(en)
|
2017-04-28 |
2023-07-11 |
Exicure Operating Company |
Synthesis of spherical nucleic acids using lipophilic moieties
|
US11433131B2
(en)
|
2017-05-11 |
2022-09-06 |
Northwestern University |
Adoptive cell therapy using spherical nucleic acids (SNAs)
|
CN111194232B
(zh)
|
2017-08-02 |
2023-01-31 |
芝加哥大学 |
纳米级金属有机层和金属有机纳米片
|
WO2019094548A1
(en)
|
2017-11-08 |
2019-05-16 |
President And Fellows Of Harvard College |
Compositions and methods for inhibiting viral vector-induced inflammatory responses
|
CN111447949A
(zh)
*
|
2017-12-15 |
2020-07-24 |
拜耳动物保健有限责任公司 |
免疫刺激寡核苷酸
|
JP2022516956A
(ja)
|
2019-01-08 |
2022-03-03 |
ハー・ルンドベック・アクチエゼルスカベット |
抗cgrp抗体を用いた頭痛の急性治療及び迅速治療
|
TW202128217A
(zh)
*
|
2019-12-13 |
2021-08-01 |
大陸商遠大賽威信生命科學(南京)有限公司 |
醫藥組合物及其用途
|
US20230241196A1
(en)
|
2020-01-27 |
2023-08-03 |
Oregon State University |
Gonorrhea subunit vaccine
|
CN114181888B
(zh)
*
|
2021-11-24 |
2023-12-08 |
汕头大学 |
一种浅色黄姑鱼鱼鳔细胞系的建立方法及应用
|
CN115252603A
(zh)
*
|
2022-07-08 |
2022-11-01 |
深圳市第二人民医院(深圳市转化医学研究院) |
indisulam在制备治疗膀胱癌的药物中的应用
|